BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martínez-Rodríguez F, Limones-González JE, Mendoza-Almanza B, Esparza-Ibarra EL, Gallegos-Flores PI, Ayala-Luján JL, Godina-González S, Salinas E, Mendoza-Almanza G. Understanding Cervical Cancer through Proteomics. Cells 2021;10:1854. [PMID: 34440623 DOI: 10.3390/cells10081854] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu Y, Shi T, Gu S, Li Y, Yang X, Fan Q, Wang Y. A novel cervix carcinoma biomarker: Pathological-epigenomics, integrated analysis of MethylMix algorithm and pathology for predicting response to cancer immunotherapy. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1053800] [Reference Citation Analysis]
2 Pereira MDL, Levy M, Nissapatorn V, de Oliveira GLV. Editorial: Women in microbiome in health and disease 2021. Front Cell Infect Microbiol 2022;12:1054190. [DOI: 10.3389/fcimb.2022.1054190] [Reference Citation Analysis]
3 Arip M, Tan LF, Jayaraj R, Abdullah M, Rajagopal M, Selvaraja M. Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review. Discov Oncol 2022;13:91. [PMID: 36152065 DOI: 10.1007/s12672-022-00551-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kokhdan EP, Ataeyan MH, Rameyan P, Alizadeh F, Khodavandi A. Total protein of Candida species inhibits human cervical cancer HeLa cells proliferation by down-regulating octamer binding transcription factor 4B.. [DOI: 10.21203/rs.3.rs-2028419/v1] [Reference Citation Analysis]
5 Poniewierza P, Panek G. Cervical Cancer Prophylaxis—State-of-the-Art and Perspectives. Healthcare 2022;10:1325. [DOI: 10.3390/healthcare10071325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zheng X, Xu S, Wu J. Cervical Cancer Imaging Features Associated With ADRB1 as a Risk Factor for Cerebral Neurovascular Metastases. Front Neurol 2022;13:905761. [DOI: 10.3389/fneur.2022.905761] [Reference Citation Analysis]
7 Shidham VB. Role of immunocytochemistry in cervical cancer screening. Cytojournal 2022;19:42. [DOI: 10.25259/cmas_03_17_2022] [Reference Citation Analysis]
8 Mukherjee A, Pednekar CB, Kolke SS, Kattimani M, Duraisamy S, Burli AR, Gupta S, Srivastava S. Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer. Proteomes 2022;10:13. [DOI: 10.3390/proteomes10020013] [Reference Citation Analysis]
9 Hamadyanova AU, Sultanmuratova AS, Disbiyanova AK, Akhmadeyeva SN, Yadgarov NO, Burangulova LE. The role of proteomics in the modern diagnosis of cervical cancer. Journal of obstetrics and women's diseases 2022;71:113-122. [DOI: 10.17816/jowd83961] [Reference Citation Analysis]
10 Manzanares-leal GL, Coronel-martínez JA, Rodríguez-morales M, Rangel-cuevas I, Bustamante-montes LP, Sandoval-trujillo H, Ramírez-durán N. Preliminary Identification of the Aerobic Cervicovaginal Microbiota in Mexican Women With Cervical Cancer as the First Step Towards Metagenomic Studies. Front Cell Infect Microbiol 2022;12:838491. [DOI: 10.3389/fcimb.2022.838491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Milenković S. HPV detection and/or cytological diagnostics. Glas javnog zdr 2022;96:313-322. [DOI: 10.5937/serbjph2203313m] [Reference Citation Analysis]
12 Thompson M, Ahmadi S, Davoudian K, De La Franier B, Lotay N, Bernardini MQ. Sensor detection in gynaecological medicine. Sens Diagn 2022;1:877-901. [DOI: 10.1039/d2sd00090c] [Reference Citation Analysis]
13 Oh TI, Kang MJ, Jeong YJ, Zhang T, Yeo SG, Park DC. Tissue Characterization Using an Electrical Bioimpedance Spectroscopy-Based Multi-Electrode Probe to Screen for Cervical Intraepithelial Neoplasia. Diagnostics 2021;11:2354. [DOI: 10.3390/diagnostics11122354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]